Results 61 to 70 of about 348,699 (383)

Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology [PDF]

Anais Brasileiros de Dermatologia, 2019
: BACKGROUND: Atopic dermatitis is a highly prevalent inflammatory and pruritic dermatosis with a multifactorial etiology, which includes skin barrier defects, immune dysfunction, and microbiome alterations.
Valeria Aoki, Daniel Lorenzini, Raquel Leão Orfali, Mariana Colombini Zaniboni, Zilda Najjar Prado de Oliveira, Maria Cecília Rivitti-Machado, Roberto Takaoka, Magda Blessmann Weber, Tania Cestari, Bernardo Gontijo, Andrea Machado Coelho Ramos, Claudia Marcia de Resende Silva, Silmara da Costa Pereira Cestari, Silvia Souto-Mayor, Francisca Regina Carneiro, Ana Maria Mosca de Cerqueira, Cristina Laczynski, Mario Cezar Pires   +17 more
doaj   +1 more source

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches

Frontiers in Immunology
Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin disease characterized by red pruritic skin lesions, xerosis, ichthyosis, and skin pain.
Moeina Afshari, M. Kolácková, Michaela Rosecka, J. Čelakovská, J. Krejsek   +4 more
semanticscholar   +1 more source

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases [PDF]

, 2004
Fluticasone propionate - the first carbothioate corticosteroid - has been classified as a potent anti-inflammatory drug for dermatological use. It is available as 0.05% cream and 0.005% ointment formulations for the acute and maintenance treatment of ...
Atsuta J, Boner AL, Bridgman A, Callen J, Delescluse J, Dooms-Goossens AE, Dykes PJ, Falcoz C, Fisher DA, Goossens A, Harding SM, Hogger P, James M, Johnson M, Johnson M, Juhlin L, Katz HI, Korting HC, Lebwohl M, Li JT, Liu XQ, Llewellyn-Jones CG, Lucky AW, McKenzie AW, McLean HM, Nurnberger FG, Phillipps GH, Roberts DT, Spencer CM, Tharp MD, Venning VA, Wilkinson SM, Wolkerstorfer A, Young MMR   +33 more
core   +1 more source

Association between Resistin Gene Polymorphisms and Atopic Dermatitis

Biomolecules, 2018
Atopic dermatitis (AD) is a chronic, relapsing, and inflammatory skin disorder. It is characterized by an inappropriate skin barrier function, allergen sensitization, and recurrent skin infections. Resistin is an adipokine expressed mainly in macrophages
Saleem A. Banihani, Khawla F. Abu-Alia, Omar F. Khabour, Karem H. Alzoubi   +3 more
doaj   +1 more source

Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects

Acta Dermato-Venereologica, 2020
Atopic dermatitis (AD) is a common, complex trait, arising from the interplay of multiple genetic and environmental factors. This review provides an overview of developments in the field of AD genetics.
Sara J. Brown, M. S. Elias, M. Bradley
semanticscholar   +1 more source

Adult Patients with Atopic Eczema have a High Burden of Psychiatric Disease: A Finnish Nationwide Registry Study

Acta Dermato-Venereologica, 2019
Atopic dermatitis is associated with several comorbidities. Epidemiological studies on psychiatric comorbidities in adult atopic dermatitis patients are sparse. We analyzed psychiatric comorbidities in a Finnish nationwide adult atopic dermatitis cohort.
Saana Kauppi, Jari Jokelainen, Markku Timonen, Kaisa Tasanen, Laura Huilaja   +4 more
doaj   +1 more source

Correlation of nipple eczema in pregnancy with atopic dermatitis in Northern India: a study of 100 cases [PDF]

Anais Brasileiros de Dermatologia
Background Nipple eczema is a less common presentation of atopic dermatitis. No studies in the literature have correlated nipple eczema in pregnancy as a manifestation of atopic dermatitis.
Anita Puri, Anisha Sethi, Karan Jit Pal Singh Puri, Anmol Sharma   +3 more
doaj   +2 more sources

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis

JAMA dermatology, 2020
This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα ...
E. Guttman‐Yassky, A. Blauvelt, L. Eichenfield, A. Paller, A. Armstrong, J. Drew, R. Gopalan, E. Simpson   +7 more
semanticscholar   +1 more source

Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis

Acta Dermato-Venereologica, 2023
There is a lack of knowledge concerning loneliness and psychiatric disorders other than anxiety and depression in patients with atopic dermatitis. This cross-sectional study was conducted within the Lifelines Cohort Study, in the Netherlands, by sending ...
Junfen Zhang, Laura Loman, Jantje M. Oldhoff, Marie L.A. Schuttelaar   +3 more
doaj   +1 more source

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

JAMA dermatology, 2020
Key Points Question What is the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid (TCS) therapy in adults with moderate to severe atopic dermatitis (AD)?
K. Reich, K. Kabashima, K. Peris, J. Silverberg, L. Eichenfield, T. Bieber, A. Kaszuba, Jill Kolodsick, F. Yang, M. Gamalo, D. Brinker, A. DeLozier, J. Janes, F. Nunes, J. Thyssen, E. Simpson   +15 more
semanticscholar   +1 more source